Do vasoactive medications impact donor hearts clinical outcomes in pediatric heart transplantation?

David BlitzerSeth LiretteLauren KaneJack G CopelandDavid A BaranHannah Copeland

Published in: Pediatric transplantation (2023)

There is no difference in pediatric OHT outcomes when the cardiac donor is treated with vasoactive infusions at procurement. Vasopressin and dobutamine were associated with improved outcomes. This information can be used to guide medical management and donor selection.

Keyphrases

healthcare
heart failure
health information
metabolic syndrome
skeletal muscle
social media
newly diagnosed
atrial fibrillation